Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Significant enrichments of pathways related to toxoplasmosis; positive regulation of protein serine/threonine kinase activity, transferase activity, and MAP kinase activity; modulation of T-cell activation and inflammatory responses; vitamin D in inflammatory disease; Yersinia infection; signaling of RANKL/RANK, C-type lectin receptors, T-cell receptors, NF-κB, Ebstein-Barr virus LMP1, and cell surface receptors wer found: all significant after FDR (Fig. 4d: f and Supplementary Data 9).

Source: Protein concentration differences by age at diagnosis. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

As this was an observational cohort study using existing biobank material, sample sizes were determined by sample availability and are consistent with prior multi-omic studies of early-life T1D risk.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The inflammatory path toward type 1 diabetes begins during pregnancy

Cohort study · Nature Communications · 2026

Original publication title

The inflammatory path toward type 1 diabetes begins during pregnancy

Angelica P. Ahrens; Raquel Dias; Tuulia Hyötyläinen; Matej Orešič; Eric W. Triplett; Johnny Ludvigsson

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Type 1 diabetes (T1D) is increasing globally, yet the earliest biological determinants remain poorly defined, particularly in general population studies. We studied the Swedish population-based ABIS birth cohort (n = 16,683) to identify early-life risk factors. Olink proteomic analysis (n = 286 controls, n = 146 cases) of inflammatory signals at birth shows differential abundance years before diagnosis (mean age 12.6 years), with proteins enriched for neutrophil migration, cytotoxicity, extracellular matrix remodeling, and immune regulation. Several markers remain significant in spite of prenatal and perinatal factors including family history of diabetes, and are associated with differences in compounds like stearic acid, lysine, glutamine, and persistent, environmental toxicants perfluorodecylethanoic acid and perfluorooctane sulfonate (PFOS).

Using machine learning, we identify a protein subset that predicts T1D with high accuracy (AUC = 0.89 ± 0.02), independently of HLA genetic risk. These findings suggest that innate and tissue-remodeling pathways are perturbed at birth, possibly reflecting early β-cell vulnerability. Identifying these disruptions at birth with a non-invasive method opens a window for prevention, protecting β-cells before the inflammatory attack on islets begins.

Screening methods to predict the development of type 1 diabetes (T1D) prior to pancreatic β-cell disruption are currently lacking. Here, the authors perform proteomics analysis of cord serum samples obtained from a Swedish birth cohort and identify an inflammatory signature predictive of disease development with good accuracy, suggesting that an inflammatory stage during pregnancy predisposes to T1D.

Authors’ abstract

Type 1 diabetes (T1D) is increasing globally, yet the earliest biological determinants remain poorly defined, particularly in general population studies. We studied the Swedish population-based ABIS birth cohort (n = 16,683) to identify early-life risk factors. Olink proteomic analysis (n = 286 controls, n = 146 cases) of inflammatory signals at birth shows differential abundance years before diagnosis (mean age 12.6 years), with proteins enriched for neutrophil migration, cytotoxicity, extracellular matrix remodeling, and immune regulation. Several markers remain significant in spite of prenatal and perinatal factors including family history of diabetes, and are associated with differences in compounds like stearic acid, lysine, glutamine, and persistent, environmental toxicants perfluorodecylethanoic acid and perfluorooctane sulfonate (PFOS).

Using machine learning, we identify a protein subset that predicts T1D with high accuracy (AUC = 0.89 ± 0.02), independently of HLA genetic risk. These findings suggest that innate and tissue-remodeling pathways are perturbed at birth, possibly reflecting early β-cell vulnerability. Identifying these disruptions at birth with a non-invasive method opens a window for prevention, protecting β-cells before the inflammatory attack on islets begins.

Screening methods to predict the development of type 1 diabetes (T1D) prior to pancreatic β-cell disruption are currently lacking. Here, the authors perform proteomics analysis of cord serum samples obtained from a Swedish birth cohort and identify an inflammatory signature predictive of disease development with good accuracy, suggesting that an inflammatory stage during pregnancy predisposes to T1D.

Publication and source details

Original title: The inflammatory path toward type 1 diabetes begins during pregnancy

Angelica P. Ahrens; Raquel Dias; Tuulia Hyötyläinen; Matej Orešič; Eric W. Triplett; Johnny Ludvigsson

Nature Communications · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/100010661EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)101094099101094099101094099Hyötyläinen Tuulia Triplett Eric W. Ludvigsson Johnny https://doi.org/10.13039/501100004973Barndiabetesfondenhttps://doi.org/10.13039/100010805Forskningsrådet i Sydöstra Sverige (Medical Research Council of Southeast Sweden)

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:37:35.505456+00:00

DOI: 10.1038/s41467-025-67712-6 · PMC12847856